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June Supplement 20106S Abstractspatients (24.4%) at some point during routine surveillance,
including, Type I (n  56, 23.0%), Type II (n  166,
68.3%), Type III (n  11, 4.5%), Type IV (n  2, 0.8%),
and Type V (n 8, 3.3%). One hundred and seven second-
ary interventions were performed in 85 patients (9.2%) for
EVAR related problems, and included placement of an iliac
extender (n  36, 33.7.%), proximal cuff placement (n 
20, 18.7%), embolization of a branch vessel (n  24,
22.4%), stent graft relining (n  15, 14.0%), ligation of a
branch vessel (n  4, 3.7%) fem-fem bypass grafts (n  3,
2.8%), ilio-femoral thrombectomy (n  3, 2.8%), and
hypogastric artery stent placement (n  2, 1.9%). Sixteen
endografts (1.7%) required explantation after primary fail-
ure (10) or failed secondary intervention (6). Indications
for explant included expanding size or persistent endoleak
(n  12), infection (n  2), and rupture (2). Three
instances of rupture following EVAR were noted.
Conclusions: Secondary aneurysm related procedures
after EVAR were required in10% of this population with
most requiring minimally invasive catheter based proce-
dures. Long-term surveillance remains important to pro-
vide optimal vascular outcomes for these patients.
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A Comparison of Indirect Radiation Dose Estimates
With Directly Measured Radiation Dose for Patients
and Operators During Complex Endovascular
Procedures
Giuseppe Panuccio, Roy K. Greenberg, Kevin Wunderle,
Tara Mastracci, Matthew J. Eagleton, William Davros.
Vascular Surgery, Cleveland Clinic Foundation, Cleveland,
OH
Objectives:To assess the accuracy of indirect estimated
radiation doses during endovascular thoracoabdominal an-
eurysm repair (eTAAA).
Methods: Patients undergoing eTAAA had imaging
system generated indirect radiation parameters recorded
concurrently with direct measurements of radiation expo-
sure patterns using radiochromatic film. Operator dose was
determined by electronic dosimeters. Observed radiation
exposure patterns were reproduced in phantoms allowing
for effective radiation dose calculations. Continuous vari-
ables were assessed with scatter plots and Pearson coeffi-
cients.
Results: No patients had evidence of radiation induced
skin injury. Cumulative air kerma (CAK) exceeded 15Gy in
3 patients, however, direct measurements were below
15Gy in all patients. Peak skin dose (PSD), quantified using
gafchromic film, correlated weakly with fluoroscopy time(FT) but better with CAK and kerma air product (KAP).
The formula“PSD 0.6770.257CAK”provides the best
estimate of actual PSD. The average effective dose was
119.68mSv (for type II or III eTAAA) and 76.46mSv (type
IV eTAAA). Mean operator effective dose was 0.17mSv/
case, and correlated best with KAP (r 0.82, p 0.0001).
Conclusions: FT, CAK and KAP represent poor mark-
ers of PSD, and directly measured PSD did not correlate
with clinical events. The effective radiation dose of eTAAA
is equivalent to 2 preoperative CT scans. An operator could
perform up to 294 eTAAA annually before reaching the
maximum recommended operator dose.
Indirect calculations and direct measurements of dose
Parameters
Total
Group
(n  47)
Type II
and III
(n  18)
Type IV
(n  29)
Correlation with
measured PSD
Indirect FT (min) 104.42 140.67 81.92 r 0.55 p 0.0001
Indirect CAK (Gy) 7.45 9.64 6.09 0.80 0.0001
Indirect KAP (Gy cm2) 781.62 1005.73 642.51 0.76 0.0001
Direct Measured PSD
(Gy)
2.59 3.16 2.24
Direct 95% Isodose area
(cm2)
4.03 4.86 3.51
Direct Patient effective
dose (mSv)
Direct Procedure 87.3 112.3 71.8
Direct Diagnostic CT 34.59 34.31 34.76
Direct Operator
effective dose
(mSv)
0.17 0.23 0.13
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Venous Specific Eph-B4 Regulates Vein Graft Thick-
ening via Caveolin-1
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William C. Sessa, Alan Dardik. Yale University School of
Medicine, New Haven, CT
Objectives: Successful vein graft adaptation to the
arterial environment is critical to maintain long-term vas-
cular graft patency. However, the mechanism of vein graft
adaptation remains unclear. Since Eph-B4, an embryonic
determinant of venous identity, expression is reduced dur-
ing vein graft adaptation, we determined whether Eph-B4,
and the shear stress-sensing caveolin-1 (cav-1), play mech-
anistic roles to limit wall thickening during vein graft
adaptation.
Methods: Full length mouse Eph-B4 cDNA was in-
serted into the pShuttle-IRES-hrGFP2 vector and the
cav-1 binding domain (CBD) was mutated at w804. In-
trathoracic inferior vena cava was harvested from wild-type
(WT) or cav-1 knockout (cav-1-KO) mice and placed as an
